Twinning in Research and Education to improve survival in Childhood Solid Tumour...
Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania
Vilnius University Hospital Santaros Klinikos (VULSK) acts as a coordinator of the TREL (Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania) project that aims to enhance translational, c...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
DIRECT
DIsseminate Research funded by EC improving Treatment option...
708K€
Cerrado
Maxima Butterfly
From Caterpillar to BUTTERFLY: supporting transformation of...
Cerrado
Maxima Butterfly
From Caterpillar to BUTTERFLY: supporting transformation of...
4M€
Cerrado
Chaperon
ERA Chair Position for Excellent Research in Oncology
2M€
Cerrado
ENCCA
EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESC...
14M€
Cerrado
SCARLET
Scaling up early and late effects research in Lithuanian chi...
1M€
Cerrado
Información proyecto TREL
Duración del proyecto: 42 meses
Fecha Inicio: 2020-06-12
Fecha Fin: 2023-12-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Vilnius University Hospital Santaros Klinikos (VULSK) acts as a coordinator of the TREL (Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania) project that aims to enhance translational, clinical and late-effect research in paediatric solid tumours (ST). The project concept is based on the existing shortcomings in paediatric oncology at VULSK and Lithuania – scarce research indicators and inferior survival rates in children with ST. TREL has a goal to increase scientific excellence in the most common paediatric ST (brain tumours, neuroblastoma and renal tumours). VULSK and 8 leading research intensive institutions each covering different areas of the project activities according to their expertise form the TREL consortium. TREL will be delivered in 7 working packages addressing training in tumour specific laboratory research and clinical trials, cross-cutting education on genome-wide sequencing and treatment innovations, enhancing skills in observational studies on the quality of survivorship including fertility preservation and research methodology as well as project and innovation management. Training exercise will focus on the implementation of secondments of VULSK staff to the partner premises, organisation of multidisciplinary transfer-of-knowledge meetings, and participation in strategic scientific meetings corresponging objectives of each working package. As a consequence of the twinning activities with internationally-leading research active counterparts VULSK will improve its research profile and reputation, enhance international, regional and national visibility and competitiveness. Fostering of existing and establishment of new networking channels will facilitate incorporation of VULSK professionals to the ongoing collaborative projects that will improve research indicators of individual researchers and VULSK as well as will increase survival rate of children with ST in Lithuania in a long-term perspective.